We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.
- Authors
Jendle, J; Nauck, M A; Matthews, D R; Frid, A; Hermansen, K; Düring, M; Zdravkovic, M; Strauss, B J; Garber, A J; LEAD-2 and LEAD-3 Study Groups
- Abstract
The effect on body composition of liraglutide, a once-daily human glucagon-like peptide-1 analogue, as monotherapy or added to metformin was examined in patients with type 2 diabetes (T2D).
- Publication
Diabetes, obesity & metabolism, 2009, Vol 11, Issue 12, p1163
- ISSN
1463-1326
- Publication type
Journal Article
- DOI
10.1111/j.1463-1326.2009.01158.x